Is IQVIA Holdings (IQV) Reasonable After A 42% 1 Year Run?

IQVIA Holdings has delivered strong share price gains in recent years, and that raises a clear question for investors: is today’s valuation still grounded in the cash the business can generate? With the stock around US$268.99 at the last close, the focus naturally shifts to what its future cash flows may be worth.

• The share price is up 41.6% over the past year, which puts real weight on whether that move matches the underlying cash flow profile.
• IQVIA’s model of providing data driven clinical research and analytics can influence how steadily it converts earnings into cash, and how predictable those cash flows may be for valuation purposes.
• Prefer to judge IQVIA Holdings on earnings? See why IQVIA Holdings's 32.2x P/E tells a different valuation story.

For investors, the debate is whether IQVIA’s current share price is appropriately supported by the intrinsic value suggested by its Discounted Cash Flow model based on those cash flows.

If you are weighing whether IQVIA Holdings’ 41.6% 1 year return aligns with its cash flows, it can help to compare that question across 31 high quality undervalued stocks.

Is IQVIA Holdings a Bargain on Cash Flow?

The Discounted Cash Flow model estimates what IQVIA Holdings might be worth based on the cash it can return to shareholders over time. On the cash side, the latest twelve month free cash flow sits around $2.16b, which gives the DCF a reasonably solid starting point rather than a turnaround story built on hopes of future improvement.

The projections behind this 2 Stage Free Cash Flow to Equity model assume that IQVIA’s free cash flow continues growing from that base, with analyst forecasts pointing to higher annual cash generation through the next decade. According to this framework, those expected cash flows support an estimated intrinsic value that is meaningfully above the current share price of $268.99. This is why some investors look at IQVIA Holdings as a stock where the market has not fully reflected its projected cash generation yet. Find out what IQVIA Holdings could be worth using our Discounted Cash Flow (DCF) estimate.

The IQVIA Holdings Narrative: What Would Justify Today's Price?

Narratives for IQVIA Holdings pick up where the valuation puzzle leaves off, spelling out which patterns in growth, margins and earnings would need to play out for the stock to be worth materially more or materially less than today's market price. Instead of resting on a single valuation multiple or model number, each narrative lays out the underlying assumptions so you can compare them with IQVIA Holdings' actual results as they arrive on Simply Wall St's Community page.

Community views on IQVIA Holdings are split between AI and backlog strength on one side and regulatory and leverage worries on the other.

Bull case: 10% undervalued

"Commercial Solutions is seeing very strong internal indicators, with the commercial pipeline growing strong double digits year to date…"

Discover why this Narrative puts IQVIA Holdings at 10% undervalued.

Bear case: 10% overvalued

"Increasing data privacy regulations worldwide, including potential future expansions of GDPR and new US federal laws, will significantly restrict IQVIA's ability to collect, process, and monetize healthcare and real-world data…"

Explore why this Narrative puts IQVIA Holdings at 10% overvalued.

An unresolved piece of the IQVIA Holdings story

One important thread still hangs loose for IQVIA Holdings, and it sits in the recent share dealings by people inside the business, where our checks highlight sales but leave the sellers, sizes and possible read throughs for you to review. See the recent insider selling flagged for IQVIA Holdings.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com